Share

October 2014; 1 (3) Clinical/Scientific NotesOpen Access

Avidity of vaccine-induced influenza IgG fails to increase in fingolimod-treated patients with MS

Matthias Mehling, Dominik Eichin, Patricia Hafner, Gideon Hönger, Ludwig Kappos, Christoph Hess
First published September 11, 2014, DOI: https://doi.org/10.1212/NXI.0000000000000028
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
804

Share

Article Information

vol. 1 no. 3 e28
DOI: 
https://doi.org/10.1212/NXI.0000000000000028
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received February 26, 2014
  • Accepted in final form August 8, 2014
  • First Published September 11, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Matthias Mehling, MD,
    2. Dominik Eichin, MSc,
    3. Patricia Hafner, MD,
    4. Gideon Hönger, BSc,
    5. Ludwig Kappos, MD* and
    6. Christoph Hess, MD, PhD*
  1. Matthias Mehling, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Dominik Eichin, MSc,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. (1) University of Turku

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Patricia Hafner, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Gideon Hönger, BSc,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Ludwig Kappos, MD* and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1)Multiple Sclerosis Journal, (2)Multiple Sclerosis and Related Disorders (3)Journal of Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. all less than 500 USD

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1)Actelion, (2)Addex,(3)Bayer Health Care,(4)Biogen Idec, (5)Biotica, (6)CSL Behring, (7)Genzyme,(8)Lilly,(9) Merck Serono, (10)Mitsubishi, (11)Novartis,(12)Ono Pharma, (13)Pfizer, (14) Receptos, (15) Roche, (16)Sanofi-aventis, (17)Santhera, (18)Siemens, (19)Teva, (20)UCB, (21)Xenoport I have also lectured at medical conferences or in public on various aspects of the diagnosis and management of multiple sclerosis. In many cases these talks have been sponsored by non-restricted educational grants from one or another of the above listed companies. Honoraria and other payments for all these activities have been exclusively used for funding of research of my department. Research and the clinical operations (nursing and patient care services) of the MS Center in Basel have been supported by non-restricted grants from one or more of these companies.

    Research Support, Government Entities:

    1. Research support by the Swiss National Research Foundation and the European Union

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. The Swiss MS Society and Novartis and Roche Research Foundations.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Christoph Hess, MD, PhD*
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Swiss National Science Foundation (310030_153059)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Immunobiology Laboratory/Department of Biomedicine and Medical Outpatient Department (M.M., D.E., G.H., C.H.) and the Department of Neurology and Clinical Neuroimmunology Laboratory/Department of Biomedicine (M.M., P.H., L.K.), University Hospital Basel, Switzerland.
  1. Correspondence to Dr. Kappos: lkappos{at}uhbs.ch or Dr. Hess: chess{at}uhbs.ch
View Full Text

Article usage

Article usage: October 2014 to March 2023

AbstractFullPdfSource
Sep 20147717417Highwire
Oct 201420112141Highwire
Nov 2014542329Highwire
Dec 20142622618Highwire
Jan 201517209Highwire
Jan 20150144pmc
Feb 20151394Highwire
Feb 20150209pmc
Mar 201529190Highwire
Mar 20150174pmc
Apr 20153252Highwire
Apr 20150140pmc
May 20152171Highwire
May 20150102pmc
Jun 20154646Highwire
Jun 20150155pmc
Jul 20152937Highwire
Jul 2015072pmc
Aug 201544710Highwire
Aug 20150162pmc
Sep 20151974Highwire
Sep 20150111pmc
Oct 20152044Highwire
Oct 20150111pmc
Nov 20151993Highwire
Nov 2015081pmc
Dec 20152311Highwire
Dec 20150131pmc
Jan 20162474Highwire
Jan 20160112pmc
Feb 20161962Highwire
Feb 2016052pmc
Mar 201623231Highwire
Mar 2016031pmc
Apr 20162142Highwire
Apr 2016042pmc
May 20163575Highwire
May 2016043pmc
Jun 20162953Highwire
Jun 2016091pmc
Jul 20162340Highwire
Jul 20160113pmc
Aug 20162540Highwire
Aug 20160131pmc
Sep 20162010Highwire
Sep 2016090pmc
Oct 20162233Highwire
Oct 2016061pmc
Nov 201617193Highwire
Nov 2016071pmc
Dec 20161620Highwire
Dec 2016090pmc
Jan 20171102Highwire
Jan 2017021pmc
Feb 2017851Highwire
Feb 2017071pmc
Mar 2017840Highwire
Mar 2017030pmc
Apr 20171911Highwire
Apr 2017169pmc
May 20172470Highwire
May 20171912pmc
Jun 20172162Highwire
Jun 2017365pmc
Jul 20171680Highwire
Jul 2017154pmc
Aug 20172181Highwire
Aug 2017289pmc
Sep 2017942Highwire
Sep 2017176pmc
Oct 2017840Highwire
Oct 2017155pmc
Nov 20171752Highwire
Nov 20171910pmc
Dec 201713190Highwire
Jan 201814160Highwire
Feb 201810152Highwire
Mar 20189220Highwire
Apr 201812302Highwire
Apr 2018366pmc
May 20188302Highwire
Jun 201814372Highwire
Jun 201801011pmc
Jul 20189371Highwire
Aug 20189271Highwire
Aug 201801113pmc
Sep 201811203Highwire
Oct 201810294Highwire
Nov 20187374Highwire
Dec 201812724Highwire
Jan 201913637Highwire
Feb 201910575Highwire
Mar 20199248Highwire
Apr 20199199Highwire
May 201912208Highwire
Jun 201911228Highwire
Jul 20197348Highwire
Aug 2019134812Highwire
Sep 20199216Highwire
Oct 2019193310Highwire
Nov 2019204221Highwire
Dec 2019111717Highwire
Jan 2020222720Highwire
Feb 2020111711Highwire
Mar 2020142122Highwire
Apr 2020034Highwire
May 2020081Highwire
Jun 2020041Highwire
Jul 20200126Highwire
Aug 2020043Highwire
Sep 2020082Highwire
Oct 20202209Highwire
Nov 202011326Highwire
Dec 20201111Highwire
Jan 202111912Highwire
Feb 2021039Highwire
Mar 20216714Highwire
Apr 20210124Highwire
May 202113148Highwire
Jun 20212101Highwire
Jul 2021264Highwire
Aug 20213133Highwire
Sep 2021287Highwire
Oct 20210816Highwire
Nov 202122019Highwire
Dec 20210147Highwire
Jan 2022062Highwire
Feb 20224589Highwire
Mar 202244710Highwire
Apr 20221143Highwire
May 202233317Highwire
Jun 20220137Highwire
Jul 2022060Highwire
Aug 20222217Highwire
Sep 202212414Highwire
Oct 20220219Highwire
Nov 202215421Highwire
Dec 20221158Highwire
Jan 20230205Highwire
Feb 20231247Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles